Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cazzaniga

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Genes, Chromosomes & Cancer|November 7, 2000
t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemiaS Tosi, J Harbott, A Teigler-Schlegel, et al.
Leukemia|November 13, 2009
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4M Bardini, R Spinelli, S Bungaro, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Leukemia|June 9, 2006
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksF J T Staal, G Cario, G Cazzaniga, et al.
Leukemia|March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsP Gorello, G Cazzaniga, F Alberti, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|July 16, 2016
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study groupE Manara, G Basso, M Zampini, et al.
Leukemia|March 24, 2017
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALLA M Savino, J Sarno, L Trentin, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Genes, Chromosomes & Cancer|November 7, 2000
t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemiaS Tosi, J Harbott, A Teigler-Schlegel, et al.
Leukemia|November 13, 2009
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4M Bardini, R Spinelli, S Bungaro, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Blood|July 15, 1997
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study GroupA Borkhardt, G Cazzaniga, S Viehmann, et al.
Leukemia|June 9, 2006
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksF J T Staal, G Cario, G Cazzaniga, et al.
Leukemia|March 17, 2006
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutationsP Gorello, G Cazzaniga, F Alberti, et al.
Leukemia|October 24, 2003
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemiasS Hübner, G Cazzaniga, T Flohr, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia|July 16, 2016
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study groupE Manara, G Basso, M Zampini, et al.
Leukemia|March 24, 2017
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALLA M Savino, J Sarno, L Trentin, et al.
Pageof 7